Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

German (DAX) Chemicals Industry Analysis

UpdatedFeb 25, 2026
DataAggregated Company Financials
Companies17
  • 7D-1.3%
  • 3M9.3%
  • 1Y-5.0%
  • YTD9.6%

Over the last 7 days, the Chemicals industry has dropped 1.3%, driven by BASF declining 3.5%. Overall the industry is down 5.0% in 12 months. Looking forward, earnings are forecast to grow by 33% annually.

Industry Valuation and Performance

Has the German Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 25 Feb 2026€88.0b€118.7b-€525,643,150.3520.4x-167.4x0.7x
Fri, 23 Jan 2026€83.4b€118.9b-€1,065,651,779.2222.7x-78.2x0.7x
Sun, 21 Dec 2025€79.9b€118.9b-€1,065,574,751.5821.3x-75x0.7x
Tue, 18 Nov 2025€79.1b€118.9b-€1,065,225,761.3520.8x-74.3x0.7x
Thu, 16 Oct 2025€81.0b€120.6b-€417,454,872.9720.2x-193.9x0.7x
Sat, 13 Sep 2025€83.2b€120.6b-€417,707,544.7321.6x-199.2x0.7x
Mon, 11 Aug 2025€86.3b€120.8b€1.3b21.4x64.6x0.7x
Wed, 09 Jul 2025€87.0b€122.0b€1.6b20.9x54.6x0.7x
Fri, 06 Jun 2025€88.8b€122.0b€1.6b21.1x55.8x0.7x
Sun, 04 May 2025€90.1b€122.2b€2.1b18.6x43.1x0.7x
Tue, 01 Apr 2025€90.2b€122.2b€2.1b18.4x42.2x0.7x
Thu, 27 Feb 2025€94.0b€122.1b€720.2m23.6x130.5x0.8x
Sat, 25 Jan 2025€88.8b€122.1b€720.2m25.4x123.4x0.7x
Mon, 23 Dec 2024€84.2b€122.1b€722.6m22.3x116.5x0.7x
Wed, 20 Nov 2024€93.8b€128.8b€644.9m19x145.4x0.7x
Fri, 18 Oct 2024€101.7b€128.8b-€331,077,792.0016.7x-307.1x0.8x
Sun, 15 Sep 2024€89.9b€122.0b-€353,077,793.0014.9x-254.7x0.7x
Tue, 13 Aug 2024€85.3b€122.0b-€387,265,620.0012x-220.2x0.7x
Thu, 11 Jul 2024€89.6b€123.4b-€573,411,639.0013.7x-156.2x0.7x
Sat, 08 Jun 2024€91.2b€123.4b-€574,854,556.0014.8x-158.6x0.7x
Mon, 06 May 2024€92.5b€124.1b-€334,841,877.5215.2x-276.4x0.7x
Wed, 03 Apr 2024€98.5b€127.2b-€39,147,483.0015.2x-2515.2x0.8x
Fri, 01 Mar 2024€88.2b€130.1b€277.6m13.4x317.7x0.7x
Sun, 28 Jan 2024€87.8b€133.6b-€2,982,235,209.0012.5x-29.4x0.7x
Tue, 26 Dec 2023€92.9b€133.6b-€2,980,615,209.0013.1x-31.2x0.7x
Thu, 23 Nov 2023€86.9b€133.6b-€2,971,386,209.0011.9x-29.2x0.7x
Sat, 21 Oct 2023€82.3b€143.9b-€701,228,845.0010x-117.3x0.6x
Mon, 18 Sep 2023€91.2b€143.9b-€699,067,209.0010.4x-130.5x0.6x
Wed, 16 Aug 2023€89.2b€144.0b-€677,443,974.009.2x-131.7x0.6x
Fri, 14 Jul 2023€91.4b€152.7b€2.6b11.7x35.8x0.6x
Sun, 11 Jun 2023€87.4b€152.7b€2.5b11.5x34.3x0.6x
Tue, 09 May 2023€93.9b€153.6b€3.2b12.4x29.5x0.6x
Thu, 06 Apr 2023€92.6b€157.4b€3.3b11.7x28.2x0.6x
Sat, 04 Mar 2023€97.6b€157.7b€4.7b10.8x20.6x0.6x
Price to Earnings Ratio

20.6x


Total Market Cap: €97.6bTotal Earnings: €4.7bTotal Revenue: €157.7bTotal Market Cap vs Earnings and Revenue0%0%0%
German Chemicals Industry Price to Earnings3Y Average -135.9x202420252026
Current Industry PE
  • Investors are relatively neutral on the German Chemicals industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 0.69x.
Past Earnings Growth
  • Total earnings for the Chemicals industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 9.1% per year, which is driving profits down.

Industry Trends

Which industries have driven the changes within the German Materials industry?

DE Market0.30%
Materials0.15%
Chemicals-1.28%
Fertilizers and Agricultural Chemicals2.90%
Specialty Chemicals1.23%
Commodity Chemicals-0.49%
Diversified Chemicals-3.50%
Industry PE
  • Investors are most optimistic about the Diversified Chemicals industry which is trading above its 3-year average PE ratio of 2.7x.
    • Analysts are expecting annual earnings growth of 23.2%, which is higher than its past year's earnings decline of 6.4% per year.
Forecasted Growth
  • Analysts are most optimistic on the Fertilizers and Agricultural Chemicals industry, expecting annual earnings growth of 105% over the next 5 years.
  • In contrast, the Commodity Chemicals industry is expected to see its earnings grow by 8.8% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
SY1 Symrise€75.942.5%
+€244.8m		-23.0%PE20.9x
SDF K+S€15.044.7%
+€121.8m		13.3%PS0.7x
ACT AlzChem Group€161.205.9%
+€90.9m		121.4%PE26.3x
WCH Wacker Chemie€82.051.3%
+€52.2m		13.2%PE187.8x
SIM0 SIMONA€52.007.0%
+€20.4m		3.0%PE19.3x

Latest News

BAS
€48.91
BASF
7D
-2.0%
1Y
-1.6%

BAS: Policy Support And Carbon Tax Deferral Will Shape Earnings Outlook

Narrative update on BASF The analyst price target for BASF has been adjusted to €62.00 per share. Analysts point to mixed recent ratings activity, concerns about earnings visibility and valuation, and the influence of policy support and stimulus on sentiment rather than fundamentals.
SDF
€15.04
K+S
7D
4.7%
1Y
13.3%

SDF: Higher Margins And Refined P/E Framework Will Recast This Opportunity

Analysts have lifted their price target on K+S by €1.10, reflecting updated assumptions around discount rates, revenue, profit margins and future P/E expectations. Analyst Commentary Bullish analysts point to the refreshed €1.10 higher price target as a sign that updated models are more aligned with current assumptions on discount rates, revenue, profit margins and future P/E expectations.
SY1
€75.94
Symrise
7D
2.5%
1Y
-23.0%

SY1: Recent Upgrade And Share Buyback Will Support Future Upside

Analyst Price Target Update Analysts have trimmed their price target for Symrise by about €0.66, reflecting slightly revised assumptions on fair value, discount rate, revenue growth, profit margin, and future P/E after recent research updates, including an upgrade from a major investment bank. Analyst Commentary Recent research updates on Symrise, including the upgrade at Goldman Sachs, highlight a mix of optimism about the company’s positioning and caution about execution and valuation.
EVK
€14.95
Evonik Industries
7D
-2.9%
1Y
-23.8%

EVK: Cost Discipline And Higher Future P/E Will Support Medium-Term Upside Potential

Analysts have trimmed their fair value estimate for Evonik Industries from about €20.40 to roughly €19.77. This reflects updated assumptions on growth, margins and a higher future P/E, against a backdrop of mixed recent research where some firms raised price targets and upgraded the shares, while others turned more cautious or moved to Sell.
ACT
€161.20
AlzChem Group
7D
5.9%
1Y
121.4%

ACT: New Creatine Capacity Plan Will Support Measured Long Term Upside Potential

Analysts are holding their price target for AlzChem Group steady at €165.00. They explain the unchanged view by pointing to updated assumptions that combine a slightly higher discount rate and P/E multiple with adjusted revenue growth and profit margin expectations.
LXS
€19.35
LANXESS
7D
-3.3%
1Y
-36.3%

LXS: Upgrade And Margin Execution Are Expected To Drive Bullish Repricing

LANXESS's consensus analyst price target has moved modestly lower, with recent cuts to €17 and €15 cited by analysts who point to updated assumptions around discount rates, profit margins, and forward P/E expectations. Analyst Commentary Recent research on LANXESS highlights a mix of caution and optimism, with some bullish analysts focusing on potential upside if the company can execute against current expectations on margins and earnings quality.
WCH
€82.05
Wacker Chemie
7D
1.3%
1Y
13.2%

WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple

Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.
IBU
€17.65
IBU-tec advanced materials
7D
-2.5%
1Y
174.9%
BNN
€2.76
BRAIN Biotech
7D
22.7%
1Y
-1.8%

Biological Solutions And Gene Editing Will Reshape Industrial Processes Over The Next Decade

Catalysts About BRAIN Biotech BRAIN Biotech develops and produces enzyme and microbial solutions for industrial and pharmaceutical applications. What are the underlying business or industry changes driving this perspective?
2HRA
€4.38
H&R GmbH KGaA
7D
-1.8%
1Y
27.3%
NTG
€12.85
Nabaltec
7D
3.6%
1Y
-10.1%
SIM0
€52.00
SIMONA
7D
7.0%
1Y
3.0%
3330
€2.66
Rostra
7D
33.0%
1Y
n/a